Northwest Biotherapeutics, Inc. (NWBO) .
このページで証明された基準:
SharesGrow 総合スコア： 25/100 0/7 項目が合格。
| Year | EPS（希薄化後） | 売上高 | 純利益 | 純利益率 |
|---|---|---|---|---|
| 2015 | $-1.48 | $1.74M | $-114.74M | -6598.1% |
| 2016 | $-0.77 | $623K | $-80.21M | -12875.4% |
| 2017 | $-0.31 | $336K | $-73.14M | -21768.8% |
| 2018 | $-0.12 | $412K | $-35.79M | -8687.9% |
| 2019 | $-0.04 | $2.41M | $-20.81M | -863.6% |
| 2020 | $-0.73 | $1.29M | $-529.82M | -41039.6% |
| 2021 | $-0.06 | $1.01M | $179.13M | 17823.5% |
| 2022 | $-0.10 | $1.68M | $-105.03M | -6240.8% |
| 2023 | $-0.06 | $1.93M | $-62.6M | -3240.1% |
| 2024 | $-0.07 | $1.38M | $-83.78M | -6062.1% |
